Does SACUBITRIL\VALSARTAN Cause Hypervolaemia? 115 Reports in FDA Database
Lower Your Cholesterol — The Natural Way
The Oxidized Cholesterol Strategy: a science-backed plan for heart health.
According to the FDA Adverse Event Reporting System (FAERS), 115 reports of Hypervolaemia have been filed in association with SACUBITRIL\VALSARTAN. This represents 0.1% of all adverse event reports for SACUBITRIL\VALSARTAN.
115
Reports of Hypervolaemia with SACUBITRIL\VALSARTAN
0.1%
of all SACUBITRIL\VALSARTAN reports
6
Deaths
86
Hospitalizations
How Dangerous Is Hypervolaemia From SACUBITRIL\VALSARTAN?
Of the 115 reports, 6 (5.2%) resulted in death, 86 (74.8%) required hospitalization, and 9 (7.8%) were considered life-threatening.
Is Hypervolaemia Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for SACUBITRIL\VALSARTAN. However, 115 reports have been filed with the FAERS database.
What Other Side Effects Does SACUBITRIL\VALSARTAN Cause?
Hypotension (11,718)
Death (9,605)
Dyspnoea (8,952)
Dizziness (8,548)
Fatigue (8,172)
Wrong technique in product usage process (8,022)
Cough (7,743)
Weight decreased (5,030)
Cardiac failure (4,504)
Malaise (4,299)
What Other Drugs Cause Hypervolaemia?
TREPROSTINIL (580)
CALCIUM\DEXTROSE\MAGNESIUM\SODIUM\SODIUM (428)
AMBRISENTAN (205)
MACITENTAN (202)
FUROSEMIDE (139)
AMLODIPINE (122)
CYCLOPHOSPHAMIDE (118)
TACROLIMUS (100)
PREDNISONE (98)
MYCOPHENOLATE MOFETIL (89)
Which SACUBITRIL\VALSARTAN Alternatives Have Lower Hypervolaemia Risk?
SACUBITRIL\VALSARTAN vs SAFINAMIDE
SACUBITRIL\VALSARTAN vs SAIZEN
SACUBITRIL\VALSARTAN vs SALICYLATE
SACUBITRIL\VALSARTAN vs SALICYLIC ACID
SACUBITRIL\VALSARTAN vs SALMETEROL